Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Mar;78(3):240–244. doi: 10.1136/adc.78.3.240

Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch-Schönlein purpura

M Fujieda 1, N Oishi 1, K Naruse 1, M Hashizume 1, K Nishiya 1, T Kurashige 1, K Ito 1
PMCID: PMC1717496  PMID: 9613354

Abstract

AIM—To evaluate the clinical significance of soluble thrombomodulin and antiendothelial cell antibodies (AECA) in children with Henoch-Schönlein purpura.
METHODS—Binding of serum AECA to bovine glomerular endothelial cells was evaluated by enzyme linked immunosorbent assay, cytotoxicity against glomerular endothelial cells by spectrophotometric assay, and soluble thrombomodulin concentrations by sandwich enzyme immunoassay.
RESULTS—IgA AECA were detected in seven of 15 patients with Henoch-Schönlein purpura and nephritis, but were not detected in patients without nephritis or in controls. Patients with Henoch-Schönlein nephritis had raised titres of IgA AECA and serum thrombomodulin; severe proteinuria and renal histological changes were associated with raised titres of IgA AECA and raised serum thrombomodulin. No subjects had complement dependent cytotoxicity against glomerular endothelial cells.
CONCLUSIONS—High titres of IgA AECA and raised serum thrombomodulin may be clinically useful markers of renal involvement in patients with Henoch-Schönlein purpura.



Full Text

The Full Text of this article is available as a PDF (123.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cerilli J., Holliday J. E., Fesperman D. P., Folger M. R. Antivascular endothelial cell antibody--its role in transplantation. Surgery. 1977 Feb;81(2):132–138. [PubMed] [Google Scholar]
  2. Cines D. B., Lyss A. P., Reeber M., Bina M., DeHoratius R. J. Presence of complement-fixing anti-endothelial cell antibodies in systemic lupus erythematosus. J Clin Invest. 1984 Mar;73(3):611–625. doi: 10.1172/JCI111251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Endo S., Inada K., Nakae H., Takakuwa T., Kasai T., Yamada Y., Suzuki T., Taniguchi S., Yoshida M. Blood levels of endothelin-1 and thrombomodulin in patients with disseminated intravascular coagulation and sepsis. Res Commun Mol Pathol Pharmacol. 1995 Nov;90(2):277–288. [PubMed] [Google Scholar]
  4. Frampton G., Jayne D. R., Perry G. J., Lockwood C. M., Cameron J. S. Autoantibodies to endothelial cells and neutrophil cytoplasmic antigens in systemic vasculitis. Clin Exp Immunol. 1990 Nov;82(2):227–232. doi: 10.1111/j.1365-2249.1990.tb05431.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Fujieda M., Oishi N., Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol. 1997 Jan;107(1):120–126. doi: 10.1046/j.1365-2249.1997.d01-894.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Hansen M. B., Nielsen S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods. 1989 May 12;119(2):203–210. doi: 10.1016/0022-1759(89)90397-9. [DOI] [PubMed] [Google Scholar]
  7. Ishii H., Majerus P. W. Thrombomodulin is present in human plasma and urine. J Clin Invest. 1985 Dec;76(6):2178–2181. doi: 10.1172/JCI112225. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ishii H., Uchiyama H., Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost. 1991 May 6;65(5):618–623. [PubMed] [Google Scholar]
  9. Iwashima Y., Sato T., Watanabe K., Ooshima E., Hiraishi S., Ishii H., Kazama M., Makino I. Elevation of plasma thrombomodulin level in diabetic patients with early diabetic nephropathy. Diabetes. 1990 Aug;39(8):983–988. doi: 10.2337/diab.39.8.983. [DOI] [PubMed] [Google Scholar]
  10. Kodama S., Uchijima E., Nagai M., Mikawatani K., Hayashi T., Suzuki K. One-step sandwich enzyme immunoassay for soluble human thrombomodulin using monoclonal antibodies. Clin Chim Acta. 1990 Dec 3;192(3):191–199. doi: 10.1016/0009-8981(90)90221-d. [DOI] [PubMed] [Google Scholar]
  11. Leung D. Y., Collins T., Lapierre L. A., Geha R. S., Pober J. S. Immunoglobulin M antibodies present in the acute phase of Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest. 1986 May;77(5):1428–1435. doi: 10.1172/JCI112454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Leung D. Y., Moake J. L., Havens P. L., Kim M., Pober J. S. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet. 1988 Jul 23;2(8604):183–186. doi: 10.1016/s0140-6736(88)92287-8. [DOI] [PubMed] [Google Scholar]
  13. Maruyama I., Bell C. E., Majerus P. W. Thrombomodulin is found on endothelium of arteries, veins, capillaries, and lymphatics, and on syncytiotrophoblast of human placenta. J Cell Biol. 1985 Aug;101(2):363–371. doi: 10.1083/jcb.101.2.363. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Matsuda M. Experimental glomerular tissue injury induced by immunization with cultured endothelial cell plasma membrane. Acta Pathol Jpn. 1988 Jul;38(7):823–839. doi: 10.1111/j.1440-1827.1988.tb02355.x. [DOI] [PubMed] [Google Scholar]
  15. Nash M. C., Shah V., Dillon M. J. Soluble cell adhesion molecules and von Willebrand factor in children with Kawasaki disease. Clin Exp Immunol. 1995 Jul;101(1):13–17. doi: 10.1111/j.1365-2249.1995.tb02270.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Nitta K., Simonson M. S., Dunn M. J. The regulation and role of prostaglandin biosynthesis in cultured bovine glomerular endothelial cells. J Am Soc Nephrol. 1991 Aug;2(2):156–163. doi: 10.1681/ASN.V22156. [DOI] [PubMed] [Google Scholar]
  17. Ohdama S., Takano S., Miyake S., Kubota T., Sato K., Aoki N. Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. Am J Clin Pathol. 1994 Jan;101(1):109–113. doi: 10.1093/ajcp/101.1.109. [DOI] [PubMed] [Google Scholar]
  18. Quadros N. P., Roberts-Thomson P. J., Gallus A. S. IgG and IgM anti-endothelial cell antibodies in patients with collagen-vascular disorders. Rheumatol Int. 1990;10(3):113–119. doi: 10.1007/BF02274825. [DOI] [PubMed] [Google Scholar]
  19. Rosenbaum J., Pottinger B. E., Woo P., Black C. M., Loizou S., Byron M. A., Pearson J. D. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol. 1988 Jun;72(3):450–456. [PMC free article] [PubMed] [Google Scholar]
  20. Suzuki K., Nishioka J., Hayashi T., Kosaka Y. Functionally active thrombomodulin is present in human platelets. J Biochem. 1988 Oct;104(4):628–632. doi: 10.1093/oxfordjournals.jbchem.a122523. [DOI] [PubMed] [Google Scholar]
  21. Söylemezoglu O., Sultan N., Gursel T., Buyan N., Hasanoglu E. Circulating adhesion molecules ICAM-1, E-selectin, and von Willebrand factor in Henoch-Schönlein purpura. Arch Dis Child. 1996 Dec;75(6):507–511. doi: 10.1136/adc.75.6.507. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tan E. M., Pearson C. M. Rheumatic disease sera reactive with capillaries in the mouse kidney. Arthritis Rheum. 1972 Jan-Feb;15(1):23–28. doi: 10.1002/art.1780150104. [DOI] [PubMed] [Google Scholar]
  23. Tanaka A., Ishii H., Hiraishi S., Kazama M., Maezawa H. Increased thrombomodulin values in plasma of diabetic men with microangiopathy. Clin Chem. 1991 Feb;37(2):269–272. [PubMed] [Google Scholar]
  24. Voskuyl A. E., Martin S., Melchers L., Zwinderman A. H., Weichselbraun I., Breedveld F. C. Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis. Br J Rheumatol. 1995 Apr;34(4):311–315. doi: 10.1093/rheumatology/34.4.311. [DOI] [PubMed] [Google Scholar]
  25. del Papa N., Meroni P. L., Barcellini W., Sinico A., Radice A., Tincani A., D'Cruz D., Nicoletti F., Borghi M. O., Khamashta M. A. Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells. Clin Immunol Immunopathol. 1992 Jun;63(3):267–274. doi: 10.1016/0090-1229(92)90232-d. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES